First Tracks Biotherapeutics (TRAX) Fair Value & DCF
TRAX$47.10-1.60 -3.29%
Market cap$1.98BEnterprise value$1.46BRevenue (TTM)$0Market position—
Score
61
Neutral
Value
34
Quality
52
Growth
98
First Tracks Biotherapeutics Inc (TRAX) trades at $47.10 on $1.98B of equity value, with a trailing P/E of -12.57. Fair value on Stocklytics blends discounted cash flow and an earnings-based cross-check when the saved model is on file. The price and ratio here are from the live quote.